Results 121 to 130 of about 90,505 (292)
Purification and Properties of an L-Arabinose Isomerase from Escherichia coli
John W. Patrick, N Lee
openalex +1 more source
Abstract Background and Purpose Immune checkpoint inhibitors, such as antiPD1, revolutionized melanoma treatment. However, resistance and low response rates remain problems. Our goal was to pinpoint actionable biomarkers of resistance to anti‐PD1 treatment and verify therapeutic effectiveness in vivo.
Szonja Anna Kovács+13 more
wiley +1 more source
Partial Purification & Properties of Xylose & Ribose Isomerase in Higher Plants [PDF]
M. H. Pubols+2 more
openalex +1 more source
PI5P4K inhibitors: promising opportunities and challenges
Developing inhibitors is like climbing a steep, challenging mountain. PI5P4K inhibitors hold significant promise for the treatment of cancer, immune disorders, and neurological diseases. However, the path to success is fraught with hurdles, and researchers are therefore required to apply their expertise to overcome critical “checkpoints.” While some ...
Koh Takeuchi+16 more
wiley +1 more source
TDP‐43 protein plays a pathological role in sporadic and familial amyotrophic lateral sclerosis (ALS). Here, we developed a cellular model overexpressing TDP‐43 with three mutations linked to familial ALS, termed ‘3X‐TDP‐43’. Mutant 3X‐TDP‐43 expression showed deficits in autophagy flux and colocalization with stress granules.
Matthew B. Dopler+20 more
wiley +1 more source
The authors identify PbfF (previously annotated as a NAD‐dependent dehydrogenase) as a hitherto unknown enzyme in phosphonate catabolism. Guided by genome context analysis, they show that PbfF is actually a racemase, serving to degrade the natural compound (S)‐2‐amino‐1‐hydroxyethylphosphonate (S‐HAEP).
Francesca Ruffolo+8 more
wiley +1 more source
TENT5C is a suppressor of ERα and GR transcriptional activation. A specific LXXLL motif in TENT5C, absent in the other members of the TENT5 subfamily, mediates a stable interaction with the Ligand Binding Domain of ERα but not with that of GR.
Yin Li+5 more
wiley +1 more source
Enzymes in cancer.III. Triosephosphate isomerase activity of human blood serum in normal individuals and in individuals with various pathological conditions [PDF]
Jacques Robert+2 more
openalex +1 more source
ON THE MECHANISM OF ACTION OF PHOSPHOGLUCOSE ISOMERASE AND PHOSPHOMANNOSE ISOMERASE
openaire +3 more sources